Abstract
Goal To investigate the frequency, time and detection of tumor recurrence. Methods During the period 1982–1992, 154 patients with a clinical stage I NSTGCT entered the study. After orchidectomy patients were followed by physical examination, serum tumormarkers AFP and HCG, chest X-rays and CT scanning of abdomen and chest. Results After median follow-up of 7 (range 2–12) years 42 patients (27.3%) had recurrent disease. All were detected within 2 years, over 90% in the first year after orchidectomy. After chemotherapy treatment for recurrence, the survival rate in the whole group was 98.7%. Early detection by: (%) Site of recurrence: (%) AFP and/or HCG (TM) 8 (19.0) Retroperitoneum (RP) 27 (64.2) TM and CT 17 (40.5) Mediastinum (M) 2 (4.8) Only CT 16 (38.1) Lungs (L) 2 (4.8) Physical examination 1 (2.4) RP and M and/or L 9 (21.4) Chest X-rays 0 (0.0) Inguinallymph nodes 2 (4.8) Conclusion For the follow-up of patients with clinical stage I NSTGCT the wait-and-see policy is a reliable method. Probably after 5 years the follow-up can be discontinued. Chest X-rays are in the follow-up of no value.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
